BridgeMD
New treatment option for Chronic Low-back Pain
Official title Weight Reduction in CLBP
ClinicalTrials.gov ID: NCT04824248
What this study is testing
- What it's testing
- We will recruit overweight/ obese participants between the age of 18 and 65 with chronic nonspecific low back pain . The participants will be randomly assigned to one of two interventions (each lasting 10 weeks).
- This is a blinded study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Overweight (BMI ≥ 25 kg/m2) or obese (BMI ≥ 30 kg/m2) with chronic low back pain
- Non-specific low back pain for at least 3 months' duration
- Currently seeking care for low back pain
- Native Dutch speaker
- Access to internet and computer/tablet/smartphone
You likely can't join if
- Leg pain of 7 or higher (on a maximum of 10) on a numeric rating scale
- Evidence of specific spinal pathology (e.g., hernia, spinal stenosis, spondylolisthesis, infection, spinal fracture or malignancy)
- Evidence of a severe underlying comorbidity (e.g. diabetes, cardiovascular problems, metabolic diseases)
- BMI ≥ 40 kg/m2
- Being pregnant or given birth in the preceding year
- Currently receiving dietary or exercise interventions
The study team makes the final eligibility decision.
Where it's taking place
- Brussels, Belgium
- Rotterdam, Netherlands
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Brussels, Belgium; Rotterdam, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.